This is indirectly related to anesthesia since we have pts with CAD.
Hypoglycaemia in patients with coronary artery disease is associated with longer hospital stays and higher mortality, according to a study presented here at the 2018 Annual Meeting of The Endocrine Society (ENDO).
Shuyang Fang, MD, Icahn School of Medicine at Mount Sinai Hospital, New York, New York, and colleagues used the National Inpatient Sample database to identify hypoglycaemic episodes among patients with stable coronary artery disease during 2014.
Among 1,262,943 patients admitted with stable coronary artery disease, 3,120 (0.24%) had an episode of hypoglycaemia — blood glucose level <70 mg/dL — defined during their inpatient stay.
Patients with hypoglycaemia were more likely to be female (47% vs 39%), be in poverty (34% vs 29%), have renal failure (32% vs 27%), and heart failure (27% vs 20%).
“Interestingly, these effects were particularly higher among patients without pre-existing diabetes,” said Dr. Fang.
Of the patients with coronary artery disease and hypoglycaemia, 10% had diabetes compared with 32% of patients without hypoglycaemia.
Compared with patients without hypoglycaemia, patients with hypoglycaemia had higher inpatient mortality rates (odds ratio [OR] = 4.48), longer hospital stays (mean 7.0 vs 5.3 days), which was associated with higher healthcare costs.
Even after adjusting for demographics (age, sex, race and income) the differences were still significant for mortality, length of stay, and healthcare costs.
The authors suggested that clinicians monitor the glucose levels of patients with coronary artery disease frequently, even those without diabetes.
[Presentation title: Associations Between Hypoglycemia and Inpatient Mortality, Length of Stay and Healthcare Cost Among Patients With Stable Coronary Artery Disease: a Nationwide Retrospective Cohort Study]